Unknown

Dataset Information

0

Activity of brentuximab vedotin in AIDS-related primary effusion lymphoma.

ABSTRACT:

SUBMITTER: Chang VA 

PROVIDER: S-EPMC6418491 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Activity of brentuximab vedotin in AIDS-related primary effusion lymphoma.

Chang Victoria A VA   Wang Huan-You HY   Reid Erin G EG  

Blood advances 20190301 5

Similar Datasets

Unknown CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma.
| S-EPMC3744990 | biostudies-literature
Unknown Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.
| S-EPMC10232850 | biostudies-literature
Unknown Brentuximab vedotin.
| S-EPMC3499340 | biostudies-literature
Unknown Brentuximab vedotin.
| S-EPMC3585690 | biostudies-literature
Unknown The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma.
| S-EPMC6910100 | biostudies-literature
Unknown Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
| S-EPMC9945772 | biostudies-literature
Unknown A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models.
| S-EPMC7549381 | biostudies-literature
Unknown Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma.
| S-EPMC5042201 | biostudies-literature
Unknown Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma.
| S-EPMC9526494 | biostudies-literature
Unknown Update on the role of brentuximab vedotin in classical Hodgkin lymphoma.
| S-EPMC6130098 | biostudies-literature